U-92032, a T-type Ca2+ channel blocker and antioxidant, reduces neuronal ischemic injuries.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  European Journal of Pharmacology

• Publication date

  1994-05-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(94)90130-9PMID 8088342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective block of transient Ca channel current in mouse neuroblastoma cells by U-88779E.

  1993cited by this paper
• Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.

  1992cited by this paper
• Neuroprotective role of adenosine in cerebral ischaemia.

  1992cited by this paper
• Calcium channel antagonists in the prevention of neurotoxicity.

  1991cited by this paper
• Molecular diversity of voltage-dependent Ca2+ channels.

  1991cited by this paper
• Calcium Channels in the Brain as Targets for the Calcium‐Channel Modulators Used in the Treatment of Neurological Disorders

  1991cited by this paper
• Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat

  1990cited by this paper
• Flunarizine selectively blocks transient calcium channel currents in N1E-115 cells.

  1990cited by this paper
• Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest in cats.

  1989cited by this paper
• Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats.

  1989cited by this paper
• Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil

  1988cited by this paper
• Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801.

  1988cited by this paper
• Glutamate neurotoxicity and diseases of the nervous system.

  1988cited by this paper
• Selective Neuronal Cell Death after Transient Forebrain Ischemia in the Mongolian Gerbil

  1988cited by this paper
• Selective neuronal death after transient forebrain ischemia in the Mongolian gerbil: a silver impregnation study.

  1988cited by this paper
• Caldueemedlated neurotoxidty: relat ship to specific channel types and role in isdemic damage

  1988cited by this paper
• Intensive anti-oxidant pretreatment retards motor nerve degeneration.

  1987cited by this paper
• Characterization of two types of calcium channels in mouse neuroblastoma cells.

  1987cited by this paper
• Effect of flunarizine on global brain ischemia in the dog: a quantitative morphologic assessment.

  1987cited by this paper
• Flunarizine, a Calcium Entry Blocker, Ameliorates Ischemic Brain Damage in the Rat

  1986cited by this paper
• Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain.

  1986cited by this paper
• Role of Lipid Peroxidation in Post-Traumatic Spinal Cord Degeneration: A Review

  1986cited by this paper
• Lipid Hydrolysis and Peroxidation in Injured Spinal Cord: Partial Protection with Methylprednisolone or Vitamin E and Selenium

  1985cited by this paper
• Isolation and kinetic analysis of inward currents in neuroblastoma cells.

  1984cited by this paper
• Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals

  1984cited by this paper
• Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

  1983cited by this paper
• Delayed neuronal death in the gerbil hippocampus following ischemia.

  1982cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Experimental cerebral infarctioneffects of pentobarbital in Mongolian gerbils.

  1977cited by this paper
• Experimental cerebral infarctioneffects of pentobarbital in Mongolian gerbils.

  1977cited by this paper
• Long‐lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path

  1973cited by this paper

• ML218 Modulates Calcium Binding Protein, Oxidative Stress, and Inflammation During Ischemia-Reperfusion Brain Injury in Mice.

  2024cites this paper
• Effect of U-92032, T-Type Ca2+ Channel Blocker, on Rats with Genetic Absence Epilepsy

  2020cites this paper
• Nicotinic Acetylcholine Receptor Signaling in Neuroprotection

  2018cites this paper
• SAK3-Induced Neuroprotection Is Mediated by Nicotinic Acetylcholine Receptors

  2018cites this paper
• The T‐type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation

  2017cites this paper
• Antioxidant‐Mediated Reversal of Oxidative Damage in Mouse Modeling of Complex I Inhibition

  2015cites this paper
• The new pyridoindole antioxidant SMe1EC2 and its intervention in hypoxia/hypoglycemia-induced impairment of longterm potentiation in rat hippocampus

  2011cites this paper
• Plant troponoids: chemistry, biological activity, and biosynthesis.

  2007cites this paper
• Antioxidants in Ischemic Stroke

  2006cites this paper
• Effect of Saffron (Crocus sativus) on Neurobehavioral and Neurochemical Changes in Cerebral Ischemia in Rats

  2006cites this paper
• Pharmacology and drug discovery for T-type calcium channels.

  2006cites this paper
• LOE 908 : A specific blocker of nonselective cation channel

  2006cites this paper
• Agonistes du recepteur opioide delta cardioprotecteur et methodes d'utilisation correspondantes

  2004cites this paper
• Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.

  2004cites this paper
• Low-Threshold Calcium Currents in Central Nervous System Neurons

  2003cites this paper
• Actions of U-92032, a T-type Ca2+ channel antagonist, support a functional linkage between I(T) and slow intrathalamic rhythms.

  2003cites this paper
• Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na(+) and Ca(2+) channel blockers with reduced affinity for dopamine D(2) receptors.

  2002cites this paper
• Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities.

  2002cites this paper
• Differential Inhibition of T-Type Calcium Channels by Neuroleptics

  2002influential citation
• Effects of ibudilast on hippocampal long-term potentiation and passive avoidance responses in rats with transient cerebral ischemia.

  2002cites this paper
• Synthesis and biological evaluation of new 4-arylpiperidines and 4-aryl-4-piperidinols: dual Na+ and Ca2+ channel blockers with reduced affinity for dopamine D2 receptors

  2002cites this paper
• REVIEW Molecular Pharmacology of T-type Ca 2 (cid:1) Channels

  2001cites this paper
• Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after forebrain ischemia.

  2001cites this paper
• Molecular pharmacology of T-type Ca2+ channels.

  2001cites this paper
• Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.

  2000cites this paper
• Flunarizine improves the survival of grafted dopaminergic neurons.

  1999cites this paper
• Efficient functional coupling of the human D3 dopamine receptor to Go subtype of G proteins in SH‐SY5Y cells

  1999cites this paper
• A novel class of Na+ and Ca2+ channel dual blockers with highly potent anti-ischemic effects.

  1999cites this paper
• cient functional coupling of the human D 3 dopamine receptor to Go subtype of G proteins in SH-SY 5 Y cells 1

  1999cites this paper
• A calcium antagonist protects against doxorubicin-induced impairment of calcium handling in neonatal rat cardiac myocytes.

  1999cites this paper
• Neuroprotective effects of a novel broad‐spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: A multispectral study

  1999cites this paper
• Elevated extracellular glutamate concentrations increased malondialdehyde production in anesthetized rat brain cortex.

  1998cites this paper
• N-type calcium channel blockers in pain and stroke

  1998cites this paper
• Inhibition by levetiracetam of a non‐GABAA receptor‐associated epileptiform effect of bicuculline in rat hippocampus

  1997cites this paper
• Ca2+ channel antagonist U-92032 inhibits both T-type Ca2+ channels and Na+ channels in hippocampal CA1 pyramidal neurons.

  1997cites this paper
• The Effects of SB 206284A, a Novel Neuronal Calcium-Channel Antagonist, in Models of Cerebral Ischemia

  1997cites this paper
• Trends and Future Developments in the Pharmacological Treatment of Acute Ischaemic Stroke

  1997cites this paper
• Na+ and high-voltage-activated Ca2+ channel blocking actions of NS-7, a novel neuroprotective agent, in NG108-15 cells.

  1997cites this paper
• Negative chronotropic and inotropic effects of U-92032, a novel T-type Ca2+ channel blocker, on the isolated, blood-perfused dog atrium.

  1996cites this paper
• Low-threshold calcium currents in central nervous system neurons.

  1996cites this paper
• New Directions in Cerebral Ischemia: Sodium and Calcium Channel Modulators

  1995cites this paper
• New drug binding sites in Ca2+ channels.

  1995cites this paper
• Lifarizine: A Blocker of Inactivated Voltage‐dependent Sodium Channels and Calcium Channels with Cerebral Neuroprotective Action

  1995cites this paper
• Pharmacology of sodium and calcium channel modulation in neurons: implications for neuroprotection.

  1995cites this paper